PharmaCyte Biotech, Inc.

New Filing
CIK: 0001157075·Pharmaceuticals·NEVADA·Filed: Jan 19, 2016
Total Offering

$3,060,000

Amount Sold

$1,020,000

Investors

2

First Sale

Jan 7, 2016

Offering Details

Type
Equity, Option to Acquire, Security to be Acquired
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Kenneth L. Waggoner
Related Person
Gerald W. Crabtree
Related Person
Thomas Liquard
Related Person

Company

PharmaCyte Biotech, Inc.

12510 PROSPERITY DRIVE, SUITE 310

SILVER SPRING, MD, 20904-1643

917-595-2850

SEC Filing

0001019687-16-004862

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
PharmaCyte Biotech, Inc. Form D Filing — $3,060,000 | FilingFlow